期刊文献+

维持性血液透析患者桡动脉钙化及其危险因素分析 被引量:5

Radial Artery Calcification and Risk Factors in Maintenance Hemodialysis Patients
下载PDF
导出
摘要 目的:探讨维持性血液透析(MHD)患者桡动脉钙化(RAC)及其危险因素。方法:收集MHD患者行自体动静脉内瘘(AVF)成形术废弃的桡动脉,行钙化染色后观察,记录一般情况和检测生化指标,多因素Logistic回归分析RAC的危险因素。结果:116例MHD患者中21例(18.1%)存在不同程度的RAC。钙化组男性比率、糖尿病发病率、透析时间、全段甲状旁腺激素(i PTH)水平较非钙化组差异有统计学意义(P<0.05),多因素Logistic回归分析结果显示,糖尿病、中位透析龄≥60个月与RAC的发生呈正相关。结论:糖尿病、中位透析龄≥60个月是MHD患者RAC的重要危险因素,男性、i PTH升高与RAC密切相关。 Objective: To investigate the status of radial artery calcification (RAC) in maintenance hemodialysis (MHD) pa- tients, and explore risk factors. Methods:Segment of radial artery were obtained from the operation of arteriovenous fistula(AVF) in MHD patients. RAC were observed by yon kossa staining. The clinical and biochemical data were collected. The parameters relating to RAC were then analyzed by binary Logistic regression analysis. Results:Among 116 cases of MHD patients ,21 cases( 18.1% )were developed RAC in different degrees. Male, diabetics, duration of dialysis, intact parathyroid hormone(iPTH) were statistical differ- ences between two groups (P 〈0.05). Binary Logistic regression analysis showed that diabetics and duration of dialysis1〉60 months were positively correlated with RAC. Conclusion : Diabetics and duration of dialysis ≥60 months were main influential factors of RAC in MHD. Male and iPTH were closely correlated with RAC.
出处 《中国中西医结合肾病杂志》 2015年第7期590-592,I0004,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 深圳市福田区卫生公益性科研项目(No.FTWS201312)
关键词 血液透析 钙化 危险因素 Hemodialysis Calcification Risk factors
  • 相关文献

参考文献16

  • 1Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross - sectional survey. Lancet, 2012,379 (9818) :815 - 822.
  • 2Hemandez D, Rufino M, Bartolomei S, et al. Clinical impact of preexistingvascular calcifications on mortality after renal trans- plantation. Kidney Int,2005,67 (14) : 2015 - 2020.
  • 3Asci G, Ok E, Savas R, et al. The link between bone and coro- nary calcifications in CKD -5. Patients on haemodialysis. Neph- rol Dial Transplant, 2011,26 ( 3 ) : 1010 - 1015.
  • 4Joosen IA, Schiphof F, Vemteylen MO, et al. Relation between mild to moderate chronic kidney disease and coronary artery dis- ease determined with coronary CT angiography. PLoS One,2012, 7(10) : e47267.
  • 5徐利鸳,刘毅,吴秀娟,郑尘非.维持性血液透析患者外周血FGF-23水平与血管钙化相关性研究[J].中国中西医结合肾病杂志,2012,13(4):323-326. 被引量:12
  • 6Chen NX, Duan D, O' Neill KD, et al. High glucose increases the expression of Cbfal and BMP - 2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant,2006, 21 (12) : 3435 - 3442.
  • 7Raggi P, Bellasi A, Ferram0sca E, et al. Association of pulse wave velocity with vascular and valvular calcification in hemodi- alysis patients. Kidney Int,2007,71 ( 8 ) : 802 - 807.
  • 8l'anikawa T, Okada Y, Tanikawa R, et al. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res, 2009,46 ( 6 ) : 572 - 580.
  • 9Yamagishi S, Fujimori H ,Yonekura H, et al. Advanced glycation endproducts accelerate calcification in microvascular perieytes. Biochem Biovhvs Res Commun.1999.258(2~ .353 -357.
  • 10Inoue T, Ogawa T, Ishida H, et al. Aortic arch calcification eval- uated on chest X - ray is a strong independent predictor of car- diovascular events in chronic hemodialysis patients. Heart Ves- sels,2012,27 (2) : 135 - 142.

二级参考文献12

  • 1London GM,Marchais SJ,Guerin AP,et al.Arteriosclerosis,vascular calcification and cardiovascular disease in uremia.Current Opinion in Nephrology and Hypertension,2005,14(6):538-542.
  • 2Rogers NM,Teubner DJ,Coates PT.Calcific uremic arteriolopathy:advances in pathog enesis and treatment.Semin Dial,2007,20(2):150-157.
  • 3Nasrallah MM,El-Shehaby AR,Salem MM,et al.Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.Nephrol Dial Transplant,2010,25(8):2679-2685.
  • 4Jean G,Terrat JC,Vanel T,et al.High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.Nephrol Dial Transplant,2009,24(9):2792-2796.
  • 5Adragao T,Pires A,Lucas C,et al.A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.Nephrol Dial Transplant,2004,19(6):1480-1488.
  • 6Ramon I,Kleynen P,Body JJ,et al.Fibroblast growth factor 23 and its role in phosphate homeostasis.Eur J Endocrinol,2010,162(1):1-10.
  • 7Yokota H,Raposo JF,Chen A,et al.Evaluation of the Role of FGF-23 in Mineral Metabolism.Gene Regul Syst Bio,2009,3(1):131-142.
  • 8Saito T,Fukumoto S.Fibroblast Growth Factor 23(FGF23) and Disorders of Phosphate Metabolism.Int J Pediatr Endocrinol 2009,2009:496514.
  • 9Gutierrez OM,Mannstadt M,Isakova T,et al.Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.N Engl J Med,2008,359(6):584-592.
  • 10Sigala F,Savvari P,Liontos M,et al.Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway.J Cell Mol Med,2010,14(9):2273-2280.

共引文献11

同被引文献29

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部